State of Wisconsin Investment Board’s VBI Vaccines, Inc. New Common Stock (Canada) VBIV Stock Holding History

State of Wisconsin Investment Board’s Portfolio VBIV Stock Details VBIV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-1,201	Closed	-$25K	–	2684
2022 Q3	$25K	Sell	1,201 -356	-23%	-$9.6K	﹤0.01%	2616
2022 Q2	$38K	Sell	1,557 -6,530	-81%	-$222K	﹤0.01%	2708
2022 Q1	$403K	Hold	8,087	–	–	﹤0.01%	2010
2021 Q4	$568K	Hold	8,087	–	–	﹤0.01%	1641
2021 Q3	$754K	Sell	8,087 -3,336	-29%	-$317K	﹤0.01%	1542
2021 Q2	$1.15M	Sell	11,423 -127	-1%	-$12.4K	﹤0.01%	1411
2021 Q1	$1.08M	Buy	11,550 +263	+2%	+$26.7K	﹤0.01%	1347
2020 Q4	$931K	Buy	11,287 +2,130	+23%	+$182K	﹤0.01%	1349
2020 Q3	$786K	Hold	9,157	–	–	﹤0.01%	1351
2020 Q2	$852K	Buy	+9,157	New	+$504K	﹤0.01%	1269
2018 Q2	–	Sell	-567	Closed	-$59K	–	1512
2018 Q1	$59K	Hold	567	–	–	﹤0.01%	1443
2017 Q4	$73K	Hold	567	–	–	﹤0.01%	1435
2017 Q3	$65K	Hold	567	–	–	﹤0.01%	1446
2017 Q2	$74K	Buy	+567	New	+$76.5K	﹤0.01%	1451

Other funds holding VBIV

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Cambridge Investment Research Advisors Fairfield, Iowa $44.6B AUM 28.94% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

GAI

General American Investors New York $1.69B AUM 40.94% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

State of Wisconsin Investment Board's VBIV Position: Q4 2022 in Review

State of Wisconsin Investment Board sold out of VBI Vaccines, Inc. New Common Stock (Canada) (VBIV) in Q4 2022, closing a stake of 1,201 shares — an estimated $25K sold.

State of Wisconsin Investment Board first reported a position in VBIV in Q2 2017 and held it in 14 quarters. The position peaked at $1.15M in Q2 2021. 112 funds tracked by Wall St. Rank hold VBIV as of Q4 2022.

State of Wisconsin Investment Board reported no remaining VBI Vaccines, Inc. New Common Stock (Canada) position as of Q4 2022 after selling out during the quarter.
State of Wisconsin Investment Board sold 1,201 VBI Vaccines, Inc. New Common Stock (Canada) shares in Q4 2022, an estimated $25K.
State of Wisconsin Investment Board first reported a position in VBI Vaccines, Inc. New Common Stock (Canada) in Q2 2017 and held it in 14 quarters.
State of Wisconsin Investment Board's VBI Vaccines, Inc. New Common Stock (Canada) position peaked at $1.15M in Q2 2021.
112 funds tracked by Wall St. Rank held VBI Vaccines, Inc. New Common Stock (Canada) as of Q4 2022.

Based on State of Wisconsin Investment Board's 13F filing for Q4 2022, filed 14 Feb 2023.